REVA Medical Inc.
5751 Copley Drive
San Diego
CA
92111
http://www.teamreva.com

Related Content

Bioresorbable stents (BRS) in development presented by Gregg Stone, M.D., during TCT 2017. Several of the players listed on the slider put their BRS development programs on hold after the negative data from the ABSORB III Trial, but a handful of smaller companies are still pushing the technology forward. #TCT #TCT2018
Feature | Stents Bioresorbable| Dave Fornell, Editor
The Next Step in Bioresorbable Stent Technologies

Bioresorbable stent (BRS) technology is not dead, but the unbridled enthusiasm seen two years ago for the technology has ...

Home October 12, 2018
arrow
A comparison of target lesion failure (TLF) of the Reva bioresorbable stent to the Absorb and top performing metallic DES. #TCT #TCT2018 #TCT18 #BRS #bioresorbablestents #bioresorbablescaffolds
News | Stents Bioresorbable
Reva Presents Key Data on its Bioresorbable Stents at TCT 2018

October 12, 2018 – Reva Medical presented four key data sets demonstrating the capabilities of the company’s Fantom ...

Home October 12, 2018
arrow
Fortitude bioresorbable stent
News | Stents Bioresorbable
TCT 2016 Investigations Examine Potential of Novel Bioresorbable Stent Technologies

November 7, 2016 — The 28th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, Oct. 29-Nov. 3 ...

Home November 07, 2016
arrow
Fantom, REVA Medical, FANTOM II trial, ACC
News
REVA Initiates FANTOM II Clinical Trial

June 5, 2015 - REVA Medical Inc. announced the initiation of patient enrollment in the FANTOM II clinical trial of its ...

Home June 05, 2015
arrow
Fantom, Reva Medical, Rutgers, bioresorbable stents
News
New Bioresorbable Stent Uses Technology to Appear on Angiographic X-ray

February 12, 2015 — A new stent for treating cardiovascular disease that incorporates a polymer invented at Rutgers, The ...

Home February 12, 2015
arrow
stents, bioresorbable, clinical trial, clinical study
News
Reva Implants First Patients With Fantom Bioresorbable Stent

December 31, 2014 — Reva Medical initiated patient enrollment with its Fantom bioresorbable drug-eluting scaffold. The ...

Home December 31, 2014
arrow
bioresorbable stents, dissolving stents, Absorb stent, BVS
Feature | Stents Bioresorbable| Dave Fornell
Bioresorbable Stents Are the Way of the Future

(UPDATE: read the Sept. 8, 2017 article "Abbott Will End Sales of Absorb Bioresorbable Stent") A key prediction for ...

Home September 03, 2014
arrow
Reva Medical ReZolve2 Bioresorbable Scaffold Stent Clinical Trial
News
Bioresorbable ReZolve2 Stent Implant Transmitted Live at TCT 2013

January 23, 2014 — An implant of the ReZolve2 bioresorbable scaffold was transmitted live via satellite at the ...

Home January 23, 2014
arrow
News
Reva Begins ReZolve2 Clinical Trial of its Bioresorbable Stent

April 2, 2013 — Reva Medical Inc. announced that it has initiated patient enrollment into a clinical trial with its ...

Home April 02, 2013
arrow
News
Initial Enrollment of ReZolve Bioresorbable Stent Trial Completed

July 16, 2012 — Reva Medical Inc. announced it completed clinical enrollment with the ReZolve drug-eluting bioresorbable ...

Home July 16, 2012
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now